Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults
Status:
Completed
Trial end date:
2023-09-27
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to evaluate whether both Form H and Form II, 100mg
brincidofovir tablets are bioequivalent, when given under fasting conditions in healthy
adults.
Participants will be randomized to each receive one tablet of Form H and one tablet of Form
II,14 days apart and undergo pharmacokinetic testing pre-dose and post-dose to evaluate
safety. This is an open-label, single-dose, randomized, two-period, crossover study.